(Q34661597)

3 August 2017

The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality (English)

1 reference

3 August 2017

1 reference

Singer JZ

1

1 reference

PubMed ID

3947418

3 August 2017

Wallace SL

series ordinal

2

1 reference

3 August 2017

1 January 1986

1 reference

3 August 2017

Arthritis & Rheumatology

1 reference

3 August 2017

29

1 reference

3 August 2017

82-87

1 reference

3 August 2017

1

1 reference

Allopurinol Associated Hypersensitivity Reactions: Cutaneous and Renal Manifestations

3 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FART.1780290111

Ocular manifestations of toxic epidermal necrolysis associated with allopurinol use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780290111

Allergic Reaction to Allopurinol with Cross-Reactivity to Oxypurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780290111

Allopurinol hepatotoxicity. Report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780290111

Drug Induced Interstitial Nephritis, Hepatitis and Exfoliative Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780290111

Possible association between macular lesions and allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780290111

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780290111

Asymptomatic Hyperuricemia: The Case for Conservative Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780290111

21 January 2018

Identifiers

DOI

10.1002/ART.1780290111

1 reference

3 August 2017

1 reference

PubMed ID

3947418